Impedimed's two blue sky opportunities
Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected
Impedimed: Getting Significant Recognition In The Medical Community
There are three small caps that look poised to end the year on a high even as the Santa Rally is starting to look like The Grinch.The so-called Santa Clause...
Vantage Point Partners
Lack of news flow has created an opportunity in IPD which has FDA approval and a full US Medicare reimbursement code that goes live on 01 January 2015 for its...